Zimmer Financial Statements From 2010 to 2024
| ZIM Stock | EUR 101.45 0.10 0.1% |
Check Zimmer Biomet financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Zimmer Biomet's main balance sheet or income statement drivers, such as , as well as many indicators such as . Zimmer financial statements analysis is a perfect complement when working with Zimmer Biomet Valuation or Volatility modules.
Zimmer |
Zimmer Biomet Holdings Company Shares Outstanding Analysis
Zimmer Biomet's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Zimmer Biomet Shares Outstanding | 210.06 M |
Most of Zimmer Biomet's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Zimmer Biomet Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, Zimmer Biomet Holdings has 210.06 M of shares currently outstending. This is 16.36% higher than that of the Healthcare sector and 20.07% higher than that of the Medical Devices industry. The shares outstanding for all Germany stocks is 63.26% higher than that of the company.
Zimmer Biomet Holdings Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Zimmer Biomet's current stock value. Our valuation model uses many indicators to compare Zimmer Biomet value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Zimmer Biomet competition to find correlations between indicators driving Zimmer Biomet's intrinsic value. More Info.Zimmer Biomet Holdings is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers reporting about 1.57 of Return On Asset per Return On Equity. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Zimmer Biomet's earnings, one of the primary drivers of an investment's value.About Zimmer Biomet Financial Statements
Zimmer Biomet stakeholders use historical fundamental indicators, such as Zimmer Biomet's revenue or net income, to determine how well the company is positioned to perform in the future. Although Zimmer Biomet investors may analyze each financial statement separately, they are all interrelated. For example, changes in Zimmer Biomet's assets and liabilities are reflected in the revenues and expenses on Zimmer Biomet's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Zimmer Biomet Holdings. Please read more on our technical analysis and fundamental analysis pages.
Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana. ZIMMER BIOMET operates under Medical Devices classification in Germany and is traded on Frankfurt Stock Exchange. It employs 19000 people.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Zimmer Stock
When determining whether Zimmer Biomet Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zimmer Biomet's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zimmer Biomet Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zimmer Biomet Holdings Stock:Check out the analysis of Zimmer Biomet Correlation against competitors. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.